课题基金 / 基金详情

项目摘要

项目成果

Judith Mary Eileen Walsh的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):癌症筛查可以挽救生命,对于50岁及以上的男性和女性,建议进行几种癌症的常规筛查。妇女的癌症筛查包括乳腺癌筛查、结直肠癌筛查和定期宫颈癌筛查(通常比妇女接受筛查的频率要低)。男性癌症筛查包括结直肠癌筛查,由于前列腺癌筛查存在争议,建议采用共同决策的方法。虽然建议进行筛查,但许多人并没有接受筛查,需要新的方法来提高筛查率。在初级保健诊所进行干预是具有挑战性的。病人是带着其他医疗问题来的,而且时间和系统都有限制。我们建议开发一种新的工具,该工具将在繁忙的诊所环境中在系统中发挥作用,并将从特定患者获得的信息与提供者提示整合在一起,这将是高效的,将减轻时间限制的负担,并将为个体患者量身定制。为响应节目公告《癌症中的决策》;根据r21资助机制,我们计划开发一种创新工具,旨在提高癌症筛查率和有关癌症筛查的讨论。这个工具将是一个多媒体互动视频医生,它将评估个体在癌症筛查方面的变化阶段,并以可行和有效的方式提供针对个体变化阶段的信息。该工具的创新之处在于:1)它将专注于针对特定个体的所有推荐的癌症筛查;2)它将根据个体的变化阶段和筛查障碍进行量身定制;3)它以前没有在初级保健诊所环境中进行过测试,以促进癌症筛查,因此是一种提高癌症筛查率和讨论癌症筛查的新方法。拟建研究的具体目的如下:1。开发多组件交互式视频医生干预,包括:a)评估癌症筛查行为和变化阶段,b)交互式视频医生,以及c)生成个性化的提供者提示表(提供者警报)。2. 对80名患者进行多组件交互式视频医生干预的试点测试,以确定其在初级保健环境中的可行性和可接受性。3. 在这项对80名患者的初步研究中,评估了在视频医生干预前后接受筛查的意愿、对筛查的兴趣和变化的阶段。在未来的研究中,我们计划进行一项随机对照试验,以确定多组件交互式视频医生干预的有效性,该干预包括评估变化阶段和癌症筛查,交互式视频医生,以及针对三个结果生成个性化的提供者提示表(提供者警报):1)提高乳腺癌和结直肠癌的筛查率,2)提高参与者接受乳腺癌和结直肠癌筛查的意愿,3)增加医生与患者对宫颈癌和前列腺癌筛查的讨论。50至70岁妇女的适当癌症检查包括乳癌乳房x光检查、结直肠癌检查和定期子宫颈癌检查。男性癌症筛查包括结直肠癌筛查,由于前列腺癌筛查存在争议,建议采用共同决策的方法。我们非常需要有效的干预措施来提高癌症筛查率,我们建议开发一个多组件交互式视频医生,用于提高适合年龄的癌症筛查率。然后,我们将在初级保健诊所设置80个人进行试点测试,以评估干预前后向提供者询问筛查的意愿和筛查的兴趣。在未来的研究中,我们将在一项随机临床试验中测试该干预措施,以确定其在提高癌症筛查率和增加癌症筛查讨论方面的有效性。如果干预措施成功,它可以在许多其他环境中使用,以提高癌症筛查率。
英文摘要
DESCRIPTION (provided by applicant): Cancer screening saves lives and routine screening for several cancers is recommended for men and women aged 50 and over. Cancer screening for women includes breast cancer screening, colorectal cancer screening and periodic cervical cancer screening (often less frequently than the woman has been receiving it). Cancer screening for men includes colorectal cancer screening and because of the controversy about prostate cancer screening, a shared decision making approach is recommended. Although screening is recommended, many individuals are not being screened and novel approaches to increasing rates of screening are needed. Conducting interventions in a primary care clinic setting is challenging. Patients come in with other medical problems, and there are time and system limitations. We propose developing a novel tool that will function within the system in a busy clinic setting, and will integrate information obtained from a particular patient with provider cues and will be efficient, will relieve the burden of time constraints and will be tailored to the individual patient. In response to the program announcement Decision Making in Cancer; Single Event Decisions and consistent with the R 21 funding mechanism, we plan to develop an innovative tool which will be designed to increase rates of cancer screening and discussions about cancer screening. This tool will be a multimedia interactive Video Doctor that will assess an individual's stage of change with respect to cancer screening and will give messages targeted to individual stage of change in a feasible and efficient manner. This tool is innovative in that 1) it will focus on all recommended cancer screening for a particular individual and 2) it will be tailored to an individual's stage of change and individual barriers to screening and 3) it has not been previously been tested in a primary care clinic setting to facilitate cancer screening and is thus a novel approach to increasing rates of cancer screening and discussions about cancer screening. The specific aims of the proposed study are as follows: 1. To develop a multi-component interactive Video Doctor intervention that includes: a) assessment of cancer screening behavior and stage of change, b) an interactive Video Doctor, and c) the generation of individualized provider cue sheets (Provider Alerts). 2. To pilot test the multi-component interactive Video Doctor intervention with 80 patients for feasibility and acceptability in a primary care setting. 3. In this pilot study of 80 patients, to assess intention to be screened, interest in screening and stage of change before and after the Video Doctor intervention. In a future study, we plan to conduct a randomized controlled trial to determine the effectiveness of a multi- component interactive Video Doctor intervention which includes assessment of stage of change and cancer screening, an interactive Video Doctor, and generation of individualized provider cue sheets (Provider Alerts) on three outcomes: 1) increasing rates of breast and colorectal cancer screening, 2) increasing participants' readiness to be screened for breast and colorectal cancer, and 3) increasing physician-patient discussions about screening for cervical cancer and prostate cancer. Appropriate cancer screening for women aged 50 to 70 includes breast cancer screening with mammography, colorectal cancer screening and periodic cervical cancer screening. Cancer screening for men includes colorectal cancer screening and because prostate cancer screening is controversial, a shared decision making approach is recommended. There is a great need for effective interventions to improve rates of cancer screening and we propose developing a multi-component interactive Video Doctor that will be used to increase rates of age appropriate cancer screening. We will then pilot test it in a primary care clinic setting with 80 individuals to assess intention to ask providers about screening and interest in screening before and after the intervention. In a future study, we will test the intervention in a randomized clinical trial to determine its effectiveness in increasing rates of cancer screening and in increasing discussions about cancer screening. Should the intervention be successful, it can be used in many other settings in order to increase rates of cancer screening.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.5402/2013/935487
发表时间: 2013
期刊: ISRN preventive medicine
影响因子: --
作者: [Arora M, Gerbert B, Potter MB, Gildengorin G, Walsh JM]
通讯作者: Walsh JM
PRE-VIEW An Interactive Video Doctor to Encourage Cancer Screening
PRE-VIEW An Interactive Video Doctor to Encourage Cancer Screening
PRE-VIEW An Interactive Video Doctor to Encourage Cancer Screening
PRE-VIEW An Interactive Video Doctor to Encourage Cancer Screening
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: